Crackdown On Illegal Drugs And Unlicensed Pharmacies In Dimapur

Shillong:  In a bid to combat illegal drug sales and ensure compliance with health regulations, a team from the department of Health & Family Welfare (H&FW), Drug Control, initiated an intensive inspection of drug licenses and the sale of banned drugs in pharmacies across Dimapur. The drive will also cover Chümoukedima district.

Addressing the media at the District Hospital Dimapur (DHD), Health minister P Paiwang Konyak revealed that illegal drugs, banned by the Indian Council of Medical Research (ICMR), were being sold in some pharmacies. He warned that strict action would be taken against any pharmacy found selling such drugs.

The minister stated that the team would also verify the status of pharmacy licenses, ensuring they were properly renewed and that only qualified pharmacists were operating the establishments. He emphasized that any discrepancies would be addressed, and the ongoing checks would continue in the coming days.

Speaking to Nagaland Post, Deputy Drugs Controller Tiatoshi Amer, who also oversees licensing, explained that the state government had already initiated a crackdown on illegal drugs, in line with the ICMR’s ban on certain categories of medications.

He mentioned that some pharmacies had been found selling banned drugs and that these would be thoroughly inspected. If any such drugs were found, the pharmacy’s license would be revoked.

Additionally, the inspection would focus on pharmacies being run by unauthorized or unqualified individuals. Amer emphasized that the authorities had provided ample time for pharmacies to employ qualified pharmacists, and any failure to comply would result in serious consequences.

Pharmacies operating without valid licenses would be issued a show-cause notice, requiring them to renew their licenses. Failure to comply would lead to license cancellation.

Amer also disclosed that 49 licenses had already been suspended, and if any pharmacies were found to be operating with illegal or invalid documents, the team would recommend the cancellation of their licenses to the government.

Related Posts

Drug-free diabetes care

A hundred million Indians are affected by type-2 (non-autoimmune) diabetes; one in every five diabetic patients worldwide is an Indian. Knowing the mechanics of diabetes is crucial in designing the…

  • Pharma
  • January 27, 2025
  • 111 views
Pharma Companies May Get Time Till December To Comply With Schedule M Norms

New Delhi:  The government is likely to give an extension till December this year to the drug manufacturers to implement revised Schedule M, people aware of the matter told ET.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Drug-free diabetes care

Drug-free diabetes care

Pharma Companies May Get Time Till December To Comply With Schedule M Norms

Pharma Companies May Get Time Till December To Comply With Schedule M Norms

Rajasthan: Snakebite Caused By Highly Venomous Saw Scaled Viper, Antivenom Ineffective

Rajasthan: Snakebite Caused By Highly Venomous Saw Scaled Viper, Antivenom Ineffective

PHARMEXCIL Strengthens India-UAE Partnership

PHARMEXCIL Strengthens India-UAE Partnership

Research Could Lead To Better Medicines And New Tools In Synthetic Biology

Research Could Lead To Better Medicines And New Tools In Synthetic Biology

PCI Mandates Aadhaar-Based Attendance System For Staff

PCI Mandates Aadhaar-Based Attendance System For Staff